To study the general capacity of COVID-19 PBMCs to produce IFNα, we analyzed the basal IFNα mRNA expression at three different time points (1–4 weeks since the admission) (Figure 2E) and found it significantly reduced compared to healthy donors. The gene discussed is IFNA1; the disease is COVID-19.